Dewpoint Therapeutics logo

Dewpoint Therapeutics

Translating condensate biology into medicine.

57 employees · est. 2018 · Boston, United States

VS
Ten63 Therapeutics logo

Ten63 Therapeutics

Explore beyond, leave nothing unseen.

25 employees · est. 2018 · Durham, United States

Dewpoint Therapeutics is the larger of the two.

Side-by-Side Comparison

Dewpoint Therapeutics Ten63 Therapeutics
Founded
2018 2018
Headquarters
Boston, United States Durham, United States
Employees
57 larger 25
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series C Series A
Total Funding
$287.00M $15.90M
Funding Rounds
3 3
Services
Development of condensate modulating therapies, Preclinical and clinical trials, AI-driven target identification, Integrated drug discovery platform Generative chemistry exploration, Quantum-accurate simulations, Virtual CSO - Sentinel, Drug design for intractable diseases
Target Customers
Patients with challenging diseases, Medical researchers, Pharmaceutical companies, Healthcare providers Biotechnology companies, Pharmaceutical researchers, Healthcare institutions, Oncology research teams
Taxonomy
Biomolecular Condensates, Drug Discovery, Oncology, Neurodegeneration, Cardiopulmonary, Virology, Condensatopathy, Genetically Linked Diseases, Image Analysis, Rare Diseases, Collaboration With Pharmaceutical Partners, Platform Technology, Protein Sequestration Prevention, Biotech Innovation Therapeutics, Cancer Research, Drug Development, In Silico Platform, AI In Healthcare, Precision Medicine, Drug Resistance, Healthtech, Biotech Innovation, Durable Response, Medical Breakthroughs, Innovation In Pharmaceuticals
Website
dewpointx.com ten63tx.com
Dewpoint Therapeutics logo

About Dewpoint Therapeutics

Dewpoint Therapeutics, founded in 2018, stands at the forefront of innovative biotechnology by pioneering the application of biomolecular condensates in drug discovery, a domain previously untapped. With the compelling slogan, "Translating condensate biology into medicine," the company is focused on...

Ten63 Therapeutics logo

About Ten63 Therapeutics

Ten63 Therapeutics, founded in 2018 and based in the United States, is at the forefront of the Biotechnology, Health Care, and Pharmaceutical industries. The company is committed to revolutionizing human health by developing therapeutics that target cancer and other severe diseases. Utilizing their...

We will tell you when either one moves

BounceWatch watches Dewpoint Therapeutics and Ten63 Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dewpoint Therapeutics and Ten63 Therapeutics — by email.

Frequently Asked Questions

Dewpoint Therapeutics — Translating condensate biology into medicine.. Ten63 Therapeutics — Explore beyond, leave nothing unseen. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dewpoint Therapeutics has raised $287.00M while Ten63 Therapeutics has raised $15.90M.
Dewpoint Therapeutics and Ten63 Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dewpoint Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dewpoint Therapeutics on 15 Jun 2026, and Ten63 Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy